NATURE’S SUNSHINE PRODUCTS, INC. Debt Securities, Trading, and Equity Securities, FV-NI
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) had Debt Securities, Trading, and Equity Securities, FV-NI of $1.13 million as of 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Debt and Equity Securities
us-gaap:TradingSecurities · last filed 2026-03-10
- 2025-12-31: Debt Securities, Trading, and Equity Securities, FV-NI $1.13M.
- 2024-12-31: Debt Securities, Trading, and Equity Securities, FV-NI $915.00K.
| Period end | Debt Securities, Trading, and Equity Securities, FV-NI |
|---|---|
| 2025-12-31 | $1.13M 10-K · filed 2026-03-10 |
| 2024-12-31 | $915.00K 10-K · filed 2026-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |